Exagen Inc. (XGN) Revenue History
Exagen Inc. (XGN) annual revenue history. Get revenue data in Excel with MarketXLS.
Revenue Data
| Period | Revenue (USD) |
|---|---|
| 2019-12-31 | $40.39M |
| 2020-12-31 | $41.98M |
| 2021-12-31 | $48.30M |
| 2022-12-31 | $45.56M |
| 2023-12-31 | $52.55M |
| 2024-12-31 | $55.64M |
| 2025-12-31 | $66.58M |
How XGN compares with sector peers
| Symbol | Company | Revenue (latest fiscal year) |
|---|---|---|
| RMTI | Rockwell Medical Inc. | $69.26M |
| NTLA | Intellia Therapeutics Inc. | $67.67M |
| KURA | Kura Oncology Inc. | $67.48M |
| ENTA | Enanta Pharmaceuticals Inc. | $65.32M |
| NKTR | Nektar Therapeutics | $55.23M |
These are five companies in the same sector as XGN with a comparable annual revenue. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Exagen Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue("XGN", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | XGN | $7.77 | +1.30% | 0.01M |
| 3 | ||||
| 4 | ||||
| 5 |